BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35955854)

  • 21. Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder.
    Loi M; Bastianini S; Candini G; Rizzardi N; Medici G; Papa V; Gennaccaro L; Mottolese N; Tassinari M; Uguagliati B; Berteotti C; Martire VL; Zoccoli G; Cenacchi G; Trazzi S; Bergamini C; Ciani E
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural Bases of Atypical Whisker Responses in a Mouse Model of CDKL5 Deficiency Disorder.
    Pizzo R; Lamarca A; Sassoè-Pognetto M; Giustetto M
    Neuroscience; 2020 Oct; 445():130-143. PubMed ID: 31472213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rescue of prepulse inhibition deficit and brain mitochondrial dysfunction by pharmacological stimulation of the central serotonin receptor 7 in a mouse model of CDKL5 Deficiency Disorder.
    Vigli D; Rusconi L; Valenti D; La Montanara P; Cosentino L; Lacivita E; Leopoldo M; Amendola E; Gross C; Landsberger N; Laviola G; Kilstrup-Nielsen C; Vacca RA; De Filippis B
    Neuropharmacology; 2019 Jan; 144():104-114. PubMed ID: 30326240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDKL5 deficiency disorder in males: Five new variants and review of the literature.
    Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E
    Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDKL5-mediated developmental tuning of neuronal excitability and concomitant regulation of transcriptome.
    Liao W; Lee KZ
    Hum Mol Genet; 2023 Nov; 32(23):3276-3298. PubMed ID: 37688574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDKL5 deficiency disorder: molecular insights and mechanisms of pathogenicity to fast-track therapeutic development.
    Van Bergen NJ; Massey S; Quigley A; Rollo B; Harris AR; Kapsa RMI; Christodoulou J
    Biochem Soc Trans; 2022 Aug; 50(4):1207-1224. PubMed ID: 35997111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and Synaptic Bases of CDKL5 Disorder.
    Zhu YC; Xiong ZQ
    Dev Neurobiol; 2019 Jan; 79(1):8-19. PubMed ID: 30246934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder.
    Trazzi S; De Franceschi M; Fuchs C; Bastianini S; Viggiano R; Lupori L; Mazziotti R; Medici G; Lo Martire V; Ren E; Rimondini R; Zoccoli G; Bartesaghi R; Pizzorusso T; Ciani E
    Hum Mol Genet; 2018 May; 27(9):1572-1592. PubMed ID: 29474534
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-Related Cognitive and Motor Decline in a Mouse Model of CDKL5 Deficiency Disorder is Associated with Increased Neuronal Senescence and Death.
    Gennaccaro L; Fuchs C; Loi M; Pizzo R; Alvente S; Berteotti C; Lupori L; Sagona G; Galvani G; Gurgone A; Raspanti A; Medici G; Tassinari M; Trazzi S; Ren E; Rimondini R; Pizzorusso T; Zoccoli G; Giustetto M; Ciani E
    Aging Dis; 2021 Jun; 12(3):764-785. PubMed ID: 34094641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnenolone and pregnenolone-methyl-ether rescue neuronal defects caused by dysfunctional CLIP170 in a neuronal model of CDKL5 Deficiency Disorder.
    Barbiero I; Peroni D; Siniscalchi P; Rusconi L; Tramarin M; De Rosa R; Motta P; Bianchi M; Kilstrup-Nielsen C
    Neuropharmacology; 2020 Mar; 164():107897. PubMed ID: 31794725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral impulsivity is associated with pupillary alterations and hyperactivity in CDKL5 mutant mice.
    Viglione A; Sagona G; Carrara F; Amato G; Totaro V; Lupori L; Putignano E; Pizzorusso T; Mazziotti R
    Hum Mol Genet; 2022 Nov; 31(23):4107-4120. PubMed ID: 35861639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabidiol attenuates seizure susceptibility and behavioural deficits in adult CDKL5
    Li X; Yennawar M; Wiest A; O'Brien WT; Babrowicz B; White RS; Talos DM; Jensen FE
    Eur J Neurosci; 2024 Jun; 59(12):3337-3352. PubMed ID: 38654472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CDKL5 deficiency in adult glutamatergic neurons alters synaptic activity and causes spontaneous seizures via TrkB signaling.
    Zhu ZA; Li YY; Xu J; Xue H; Feng X; Zhu YC; Xiong ZQ
    Cell Rep; 2023 Oct; 42(10):113202. PubMed ID: 37777961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDKL5 deficiency disorder: a pathophysiology of neural maintenance.
    Kind PC; Bird A
    J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34720088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.
    Katayama S; Sueyoshi N; Inazu T; Kameshita I
    Neural Plast; 2020; 2020():6970190. PubMed ID: 32587608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder.
    Fuchs C; Rimondini R; Viggiano R; Trazzi S; De Franceschi M; Bartesaghi R; Ciani E
    Neurobiol Dis; 2015 Oct; 82():298-310. PubMed ID: 26143616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Providing quality care for people with CDKL5 deficiency disorder: A European expert panel opinion on the patient journey.
    Amin S; Møller RS; Aledo-Serrano A; Arzimanoglou A; Bager P; Jóźwiak S; Kluger GJ; López-Cabeza S; Nabbout R; Partridge CA; Schubert-Bast S; Specchio N; Kälviäinen R
    Epilepsia Open; 2024 Jun; 9(3):832-849. PubMed ID: 38450883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pregnenolone-methyl-ether enhances CLIP170 and microtubule functions improving spine maturation and hippocampal deficits related to CDKL5 deficiency.
    Barbiero I; Zamberletti E; Tramarin M; Gabaglio M; Peroni D; De Rosa R; Baldin S; Bianchi M; Rubino T; Kilstrup-Nielsen C
    Hum Mol Genet; 2022 Aug; 31(16):2738-2750. PubMed ID: 35348691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormalities of mitochondrial dynamics and bioenergetics in neuronal cells from CDKL5 deficiency disorder.
    Van Bergen NJ; Massey S; Stait T; Ellery M; Reljić B; Formosa LE; Quigley A; Dottori M; Thorburn D; Stroud DA; Christodoulou J
    Neurobiol Dis; 2021 Jul; 155():105370. PubMed ID: 33905871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel preclinical model for CDKL5 deficiency disorder.
    Serrano RJ; Lee C; Douek AM; Kaslin J; Bryson-Richardson RJ; Sztal TE
    Dis Model Mech; 2022 Mar; 15(3):. PubMed ID: 34913468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.